Allogene Therapeutics, Inc. (ALLO) by event type
ALLO moves most on analyst upgrades — a median of +2.67% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ALLO overview →
How ALLO reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 15 of 2,717 | 15 | +2.67% | 60% | +0.97% |
| Analyst downgrades 2,339 of 2,603 | 15 | -0.74% | 13% | 0.00% |
| Coverage initiations 2,210 of 2,283 | 12 | -1.89% | 25% | -3.48% |
| Rating reiterations 3,430 of 3,522 | 58 | -0.89% | 36% | -0.45% |
| Price-target cuts 1,520 of 1,527 | 14 | -1.67% | 36% | -0.32% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how ALLO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · ALLO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MATEON THERAPEUTICS (MATN) | 318 | 0.00% | 35% |
| Senseonics Holdings, Inc. (SENS) | 318 | -0.44% | 42% |
| Denali Therapeutics Inc. (DNLI) | 316 | +0.07% | 51% |
| Myomo Inc. (MYO) | 315 | +0.35% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.